The PLI scheme is a step in the right direction in fulfilling India’s domestic healthcare needs in the immediate to medium term by developing a resilient supply chain and creating an integrated pharma ecosystem.
Read More
This implies that the protection against reinfection by Omicron afforded by past infection may be as low as 19 per cent.
Read More
The ICMR-Regional Medical Research Centre, NE, Dibrugarh, one of the institutes of the ICMR, New Delhi, has developed a novel technology -- real-time RT-PCR assay for detection of Omicron (B.1.1.529) variant of SARS-CoV2 and a kit for the same.
Read More
Earlier studies from Israel and the United States have indicated an increased risk of heart inflammation after inoculation with the mRNA-vaccines developed by Pfizer-BioNTech and Moderna.
Read More
The Health Ministry in a statement said that the recovery of 8,706 patients in the last 24 hours has increased the cumulative tally of recovered patients to 3,41,71,471.
Read More
The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.
Read More
The plant was inspected by USFDA (United States Food and Drug Administration) between December 6 and December 15, 2021
Read More
The research, published in The British Medical Journal on Wednesday, showed the vaccine was effective against COVID-19 hospitalisation associated with the Delta variant.
Read More
